HighTower Advisors’s Balchem BCPC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$587K Sell
3,559
-393
-10% -$66.9K ﹤0.01% 2604
2026
Q2
$668K Sell
3,952
-1,865
-32% -$310K ﹤0.01% 2523
2026
Q1
$986K Buy
5,817
+1,483
+34% +$252K ﹤0.01% 2196
2025
Q4
$665K Buy
4,334
+784
+22% +$120K ﹤0.01% 2416
2025
Q3
$533K Buy
3,550
+1,184
+50% +$187K ﹤0.01% 2568
2025
Q2
$377K Sell
2,366
-74
-3% -$12K ﹤0.01% 2747
2025
Q1
$405K Sell
2,440
-12
-0.5% -$1.97K ﹤0.01% 2633
2024
Q4
$400K Buy
2,452
+223
+10% +$38.7K ﹤0.01% 2656
2024
Q3
$391K Buy
2,229
+295
+15% +$50.2K ﹤0.01% 2609
2024
Q2
$296K Buy
1,934
+66
+4% +$9.9K ﹤0.01% 2724
2024
Q1
$287K Buy
1,868
+54
+3% +$8.01K ﹤0.01% 2713
2023
Q4
$266K Buy
+1,814
New +$232K ﹤0.01% 2794
2023
Q3
– Sell
-1,488
Closed -$200K – 3782
2023
Q2
$200K Buy
+1,488
New +$191K ﹤0.01% 2871
2014
Q3
– Sell
-6,397
Closed -$343K – 1673
2014
Q2
$343K Buy
+6,397
New +$367K 0.01% 1198
2013
Q4
– Sell
-13,560
Closed -$707K – 1616
2013
Q3
$707K Buy
13,560
+2,627
+24% +$130K 0.02% 734
2013
Q2
$489K Buy
+10,933
New +$489K 0.01% 811

Other funds holding BCPC

HighTower Advisors's BCPC Position: Q3 2026 in Review

HighTower Advisors reduced its Balchem (BCPC) stake by 9.9% in Q3 2026, selling an estimated $66.9K and leaving 3,559 shares worth $587K. The position accounts for ﹤0.01% of the portfolio, ranked #2604.

HighTower Advisors first reported a position in BCPC in Q2 2013 and has held it in 16 quarters since. The position peaked at $986K in Q1 2026. 431 funds tracked by Wall St. Rank hold BCPC as of Q3 2026.

  • HighTower Advisors held 3,559 shares of Balchem worth $587K as of Q3 2026.
  • HighTower Advisors sold 393 Balchem shares in Q3 2026, an estimated $66.9K.
  • Balchem made up ﹤0.01% of HighTower Advisors's portfolio in Q3 2026, its #2604 holding.
  • HighTower Advisors first reported a position in Balchem in Q2 2013 and has held it in 16 quarters since.
  • HighTower Advisors's Balchem position peaked at $986K in Q1 2026.
  • 431 funds tracked by Wall St. Rank held Balchem as of Q3 2026.

Based on HighTower Advisors's 13F filing for Q3 2026, filed 10 Nov 2026.